FORM Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.5M Sell
9,538
-34
-0.4% -$8.72K 0.28% 17
2026
Q2
$2.41M Buy
9,572
+1,342
+16% +$289K 0.26% 18
2026
Q1
$1.79M Sell
8,230
-388
-5% -$86.1K 0.21% 20
2025
Q4
$1.97M Buy
+8,618
New +$1.96M 0.23% 19
2025
Q2
$1.65M Sell
8,863
-146
-2% -$27.1K 0.2% 23
2025
Q1
$1.89M Buy
+9,009
New +$1.75M 0.26% 21

Other funds holding ABBV

FORM Wealth Advisors's ABBV Position: Q3 2026 in Review

FORM Wealth Advisors reduced its AbbVie (ABBV) stake by 0.36% in Q3 2026, selling an estimated $8.72K and leaving 9,538 shares worth $2.5M. The position accounts for 0.28% of the portfolio, ranked #17.

FORM Wealth Advisors first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 1,321 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • FORM Wealth Advisors held 9,538 shares of AbbVie worth $2.5M as of Q3 2026.
  • FORM Wealth Advisors sold 34 AbbVie shares in Q3 2026, an estimated $8.72K.
  • AbbVie made up 0.28% of FORM Wealth Advisors's portfolio in Q3 2026, its #17 holding.
  • FORM Wealth Advisors first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 1,321 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on FORM Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.